Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s view of the real case discussions that take place during hepatocellular carcinoma (HCC) tumor boards. Host Dr. Zach Berman sits down with a multidisciplinary team, including Drs. Adam Burgoyne (medical oncologist), Heather Patton (hepatologist), Siddharth Padia (interventional radiologist), and Gabriel Schnickel (transplant and hepatobiliary surgeon).
Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion:
https://www.cmeuniversity.com/course/take/125743
---
This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.
---
SYNPOSIS
The team walks through a range of diverse HCC cases, reviewing patient histories, imaging, and treatment options. They cover eight cases in total, each featuring patients with varying treatment histories, comorbidities, liver function, and lesion characteristics. For the full educational experience, we recommend watching the video format on our YouTube channel.
---
TIMESTAMPS
00:00 - Introduction
00:47 - Case 1: Small Lesion in a Young Patient
05:01 - Case 2: Moderate Sized Lesion in an Older Patient
11:10 - Case 3: Multifocal HCC with Dominant Lesion
21:09 - Case 4: Dominant Lesion with Portal Hypertension
32:08 - Case 5: Ruptured Solitary Lesion
34:34 - Case 6: Rupture with Multifocal Lesions
44:08 - Case 7: Portal Vein Invasion
52:12 - Case 8: Metastatic HCC After Transplant
---
RESOURCES
CME Accreditation Information:
https://f7cae4ec-b69e-490d-9e0f-19b16a6f146d.usrfiles.com/ugd/f7cae4_a7c37ea3cd1b4d3fa53d5edf8dfe255b.pdf
